Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study
- Resource Type
- Article
- Source
- In
Clinical Breast Cancer January 2022 22(1):e74-e79 - Subject
- Language
- ISSN
- 1526-8209